Skip to content

Oxidative stress and polycystic ovarian syndrome

Oxidative stress and polycystic ovarian syndrome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCH-12002727
Enrollment
Unknown
Registered
2012-11-28
Start date
2011-06-14
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

None listed

Sponsors

Nil
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: (1) Polycystic ovary syndromeThirty women with PCOS and clinical indication for endometrial biopsy for histological examination (e.g. infertility, abnormal vaginal bleeding or increase endometrial thickness) will be recruited as study subjects. The diagnosis of PCOS is based on the latest 2003 Rotterdam consensus with at least two of the following features: (i) oligo-amenorrhoea or chronic anovulation, (ii) clinical and/or biochemical hyperandrogenism, (iii) ultrasound appearance of polycystic ovaries, after exclusion of other known causes of hyperandrogenaemia2.(2) ControlAnother thirty age- and body mass index (BMI) matched women without PCOS, who with clinical indication for endometrial biopsy for histological examination (e.g. infertility, abnormal vaginal bleeding or increase endometrial thickness) will be recruited as control subjects. All of them has regular menstrual cycles and has no hirsutism/acne or ultrasound features of polycystic ovaries.3.Women with PCOS with clinical indication for endometrial biopsy (e.g. infertility, abnormal vaginal bleeding or increase endometrial thickness) will be recruited as study subjects. The diagnosis of PCOS is based on the latest 2003 Rotterdam consensus with at least two of the following features: (i) oligo-amenorrhoea or chronic anovulation, (ii) clinical and/or biochemical hyperandrogenism, (iii) ultrasound appearance of polycystic ovaries, after exclusion of other known causes of hyperandrogenaemia2.4.Patients should not receive any treatments for PCOS within 3 months before our study

Exclusion criteria

Exclusion criteria: 1. Present of endocrinological or autoimmune disease 2. Usage of medications which are known to affect steroid or glucose metabolism (e.g. oral contraceptives, corticosteroids) within the past 3 months 3. Smoker or drinker 4. Refuse participation of study or incompetence to make informed consent.

Countries

China

Contacts

Public ContactDr. Wai Yee Wong
alicewywong@cuhk.edu.hk+852 26322583

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026